Detection of avian retroviruses in vaccines by amplification on DF-1 cells with immunostaining and fluorescent product-enhanced reverse transcriptase endpoint methods

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1496-1504

  Birmingham, Cheryl L ^a   Dupont, Dominique ^b   Riou, Patrice ^b   Armanet, Corinne ^b   Edamura, Kerrie Nichol ^a   Martinho, Briolange ^a   Serres, Aurelie ^b   Jacouton, Severine ^b   Detrez, Valerie ^b   McNeil, Bryan ^a   Schreiber, Martha ^a   Gaillac, David ^b   Bonnevay, Thierry ^b   Gisonni Lex, Lucy ^a   Mallet, Laurent ^a  

^a Sanofi Pasteur   (Canada)

^b SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VACCINE;

ANIMAL CELL; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CELL STRAIN DF 1; CHICKEN; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; DRUG INDUSTRY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE AMPLIFICATION; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VALIDATION STUDY; VIRUS IDENTIFICATION; VIRUS INFECTIVITY; ANIMAL; CELL LINE; CHICK EMBRYO; DRUG CONTAMINATION; EVALUATION STUDY; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; VIRUS REPLICATION;

AVES; AVIAN LEUKOSIS VIRUS; AVIAN RETROVIRUSES;

ANIMALS; AVIAN LEUKOSIS VIRUS; CELL LINE; CHICK EMBRYO; DRUG CONTAMINATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES; VIRUS REPLICATION;

EID: 84876780504     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03146-12     Document Type: Article

References (20)

1. European Directorate for the Quality of Medicines and Health Care. 2011. European Pharmacopoeia: tests for extraneous agents in viral vaccines for human use. Methods of analysis 2.6.16. Council of Europe, Strasbourg, France.
2. European Directorate for the Quality of Medicines and Health Care. 2009. European Pharmacopoeia: avian viral vaccines: tests for extraneous agents in seed lots. Methods of analysis 2.6.24. Council of Europe, Strasbourg, France.
3. U.S. Food and Drug Administration. 2010. Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. U.S. Food and Drug Administration, Silver Spring, MD.
4. World Health Organization Expert Committee on Biological Standardization. 2010. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks (proposed replacement of TRS 878 annex 1). World Health Organization, Geneva, Switzerland.
5. European Directorate for the Quality of Medicines and Health Care. 2009. European Pharmacopoeia: cell substrates for the production of vaccines for human use. General texts 5.2.3. Council of Europe, Strasbourg, France.
6. Boni J, Stalder J, Reigel F, Schupbach J. 1996. Detection of reverse transcriptase activity in live attenuated virus vaccines. Clin. Diagnostic Virol. 5:43-53.
7. Maudru T, Cooperating Units Peden KWC. 1998. Analysis of a coded panel of licensed vaccines by polymerase chain reaction-based reverse transcriptase assays: a collaborative study. J. Clin. Virol. 11:19-28.
8. Hussain AI, Johnson JA, da Silva Freire M, Heneine W. 2003. Identification and characterization of avian retroviruses in chicken embryoderived yellow fever vaccines: investigation of transmission to vaccine recipients. J. Virol. 77:1105-1111.
9. Hussain AI, Shanmugam V, Switzer WM, Tsang SX, Fadly A, Thea D, Helfand R, Bellini WJ, Folks TM, Heneine W. 2001. Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerg. Infect. Dis. 7:66-72.
10. Shahabuddin M, Sears JF, Khan AS. 2001. No evidence of infectious retroviruses in measles virus vaccines produced in chicken embryo cell cultures. J. Clin. Microbiol. 39:675-684.
11. Tsang SX, Switzer WM, Shanmugam V, Johnson JA, Goldsmith C, Wright A, Fadly A, Thea D, Jaffe H, Folks TM, Heneine W. 1999. Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: investigation of transmission to vaccine recipients. J. Virol. 73:5843-5851.
12. Weissmahr RN, Schupbach J, Boni J. 1997. Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA. J. Virol. 71: 3005-3012.
13. Himly M, Foster DN, Bottoli I, Iacovoni JS, Vogt PK. 1998. The DF-1 chicken fibroblast cell-line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248:295-304.
14. Schaefer-Klein J, Givol I, Barsov EV, Whitcomb JM, VanBrocklin M, Foster DN, Federspiel MJ, Hughes SH. 1998. The EV-0-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248:305-311.
15. Maas R, van Zoelen D, Oei H, Claassen I. 2006. Replacement of primary chicken embryonic fibroblasts (CEF) by the DF-1 cell-line for detection of avian leucosis viruses. Biologicals 34:177-181.
16. Lovatt A, Black J, Galbraith D, Doherty I, Moran MW, Shepherd AJ, Griffen A, Bailey A, Wilson N, Smith KT. 1999. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J. Virol. Methods 82:185-200.
17. Gibelin N, Dupont D, Imbert S, Rozet E. 2009. Use of total error concept in the validation of viral activity in cell cultures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877:2407-2411.
18. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1994. ICH harmonized tripartite guideline. Validation of analytical procedures: text and methodology Q2(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland.
19. Weiss RA. 2006. The discovery of endogenous retroviruses. Retrovirology 3:67-77.
20. Payne LN. 1998. Retrovirus-induced disease in poultry. Poult. Sci. 77: 1204-1212.